{{Rsnum
|rsid=2198843
|Chromosome=15
|position=74708889
|Orientation=minus
|GMAF=0.3669
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 1.5 | 20.0 | 78.5
| HCB | 20.0 | 60.0 | 20.0
| JPT | 22.7 | 45.5 | 31.8
| YRI | 38.1 | 41.3 | 20.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 20.0 | 60.0 | 20.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|19110417}} hepatocellular carcinoma in Chinese populations
*increased risk [[rs4646421]] (OR 1.30, 95% CI 1.05-1.61)
*increased risk [[rs2198843]] (OR 1.33, 95% CI 1.05-1.69)
*reduced risk [[rs4886605]] (OR 0.70. 95% CI 0.52-0.94)

{{PMID Auto
|PMID=18268125
|Title=Assessment of interactions between PAH exposure and genetic polymorphisms on PAH-DNA adducts in African American, Dominican, and Caucasian mothers and newborns.
|OA=1
}}

{{PMID Auto
|PMID=18632753
|Title=Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes.
|OA=1
}}

{{PMID Auto
|PMID=18691756
|Title=Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk.
|OA=1
}}

{{PMID Auto
|PMID=18798002
|Title=Coffee consumption, genetic susceptibility and bladder cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=19479063
|Title=Phase I metabolic genes and risk of lung cancer: multiple polymorphisms and mRNA expression.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}